1. Home
  2. LRN vs KYMR Comparison

LRN vs KYMR Comparison

Compare LRN & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stride Inc.

LRN

Stride Inc.

N/A

Current Price

$72.73

Market Cap

6.3B

Sector

Real Estate

ML Signal

N/A

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

N/A

Current Price

$72.40

Market Cap

6.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LRN
KYMR
Founded
2000
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
6.4B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
LRN
KYMR
Price
$72.73
$72.40
Analyst Decision
Buy
Strong Buy
Analyst Count
4
24
Target Price
$106.75
$105.35
AVG Volume (30 Days)
944.2K
694.8K
Earning Date
01-27-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
15.30
N/A
EPS
6.34
N/A
Revenue
$2,475,117,000.00
$43,735,000.00
Revenue This Year
$5.60
$18.70
Revenue Next Year
$4.69
N/A
P/E Ratio
$11.29
N/A
Revenue Growth
17.25
N/A
52 Week Low
$60.62
$19.45
52 Week High
$171.17
$103.00

Technical Indicators

Market Signals
Indicator
LRN
KYMR
Relative Strength Index (RSI) 64.01 46.20
Support Level $68.55 $66.21
Resistance Level $71.17 $76.71
Average True Range (ATR) 2.32 3.82
MACD 0.80 -0.83
Stochastic Oscillator 98.07 51.92

Price Performance

Historical Comparison
LRN
KYMR

About LRN Stride Inc.

Stride Inc is an American online educational company. It offers alternative programs to traditional on-campus schooling. It also operates state-funded virtual charter schools around the United States. The educational programs for K-12 students are usually monitored by parents and provide virtual classroom environments where teachers meet with students online, by phone, or in-person. The company's contractual agreements with various school districts to offer its curriculum programs provide a majority of the company's revenue. The company lines of business are Managed Public School Programs, Institutional and Private Pay Schools and Other.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: